Status:
COMPLETED
Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema
Lead Sponsor:
Hospital Juarez de Mexico
Conditions:
Diabetic Retinopathy
Clinically Significant Macular Edema
Eligibility:
All Genders
30-85 years
Brief Summary
Clinically significant macular edema (CSME) is a thickening of the macula associated with the risk of visual loss, which increases its centre is involved. Functional evaluation of the macula relies on...
Detailed Description
A non-experimental, comparative, prospective, cross-sectional study was conducted. Target population were type 2 diabetics, from Mexico City and its metropolitan area, and available population were ty...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients
- aged 30-85 years
- from any gender
- with central fixation
- ocular media allowed obtaining an adequate quality Optical coherence tomography
- CSME with focal angiographic pattern
Exclusion
- optic nerve or visual pathways diseases or any other ocular disease that decreased Best corrected visual acuity
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01824862
Start Date
January 1 2013
End Date
July 1 2013
Last Update
July 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virgilio Lima Gomez
Mexico City, Mexico City, Mexico, 07760